Comparison of the intestinal absorption and bioavailability of γ-tocotrienol and α-tocopherol: In vitro, in situ and in vivo studies

Biopharmaceutics and Drug Disposition

Volumn 33, Issue 5, 2012, Pages 246-256

  Abuasal, Bilal S ^a   Qosa, Hisham ^a   Sylvester, Paul W ^a   Kaddoumi, Amal ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

tocopherol; tocotrienol; carrier mediated uptake; intestinal absorption; NPC1L1

Indexed keywords

ALPHA TOCOPHEROL; CORN OIL; DRUG CARRIER; EZETIMIBE; GAMMA TOCOTRIENOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUTION; DRUG TRANSPORT; DRUG UPTAKE; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; INTESTINE PERFUSION; LIPOLYSIS; MALE; NONHUMAN; RAT;

ADMINISTRATION, ORAL; ALPHA-TOCOPHEROL; ANIMALS; AREA UNDER CURVE; AZETIDINES; BIOLOGICAL AVAILABILITY; CORN OIL; DRUG CARRIERS; GAMMA-TOCOPHEROL; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; INTESTINE, SMALL; LIPOLYSIS; MALE; MEMBRANE TRANSPORT PROTEINS; MOLECULAR STRUCTURE; PERFUSION; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 84863716186     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.1790     Document Type: Article

References (40)

1. Nagy K, Courtet-Compondu MC, Holst B, Kussmann M,. Comprehensive analysis of vitamin E constituents in human plasma by liquid chromatography-mass spectrometry. Anal Chem 2007; 79: 7087-7096. (Pubitemid 47438688)
2. Cornwell DG, Ma J,. Studies in vitamin E: biochemistry and molecular biology of tocopherol quinones. Vitam Horm 2007; 76: 99-134.
3. Yoshida Y, Hayakawa M, Itoh N, et al,. Antioxidant effects of 2,3-dihydro-5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran and alpha-tocopherol in hyperlipidemic mice as evaluated by hydroxyoctadecadienoic acid and 7-hydroxycholesterol. Biochem Pharmacol 2007; 74: 1010-1019. (Pubitemid 47284013)
4. Gohil K, Oommen S, Quach HT, et al,. Mice lacking alpha-tocopherol transfer protein gene have severe alpha-tocopherol deficiency in multiple regions of the central nervous system. Brain Res 2008; 1201: 167-176.
5. Hosomi A, Arita M, Sato Y, et al,. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 1997; 409: 105-108. (Pubitemid 27248576)
6. Shah S, Gapor A, Sylvester PW,. Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells. Nutr Cancer 2003; 45: 236-246. (Pubitemid 37022798)
7. Sen CK, Khanna S, Roy S,. Tocotrienols: vitamin E beyond tocopherols. Life Sci 2006; 78: 2088-2098.
8. Aggarwal BB, Sundaram C, Prasad S, Kannappan R,. Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol 2010; 80: 1613-1631.
9. Qureshi AA, Qureshi N, Wright JJ, et al,. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr 1991; 53: 1021S-1026S. (Pubitemid 21898866)
10. Shah SJ, Sylvester PW,. Tocotrienol-induced cytotoxicity is unrelated to mitochondrial stress apoptotic signaling in neoplastic mammary epithelial cells. Biochem Cell Biol 2005; 83: 86-95. (Pubitemid 40637970)
11. Shibata A, Nakagawa K, Sookwong P, Tsuzuki T, Oikawa S, Miyazawa T,. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol. Biochem Pharmacol 2008; 76: 330-339.
12. Yap SP, Yuen KH, Lim AB,. Influence of route of administration on the absorption and disposition of alpha-, gamma- and delta-tocotrienols in rats. J Pharm Pharmacol 2003; 55: 53-58. (Pubitemid 36142081)
13. Yap SP, Yuen KH,. Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int J Pharm 2004; 281: 67-78. (Pubitemid 39024264)
14. Dressman JB, Amidon GL, Fleisher D,. Absorption potential: estimating the fraction absorbed for orally administered compounds. J Pharm Sci 1985; 74: 588-589.
15. Barthe L, Woodley J, Houin G,. Gastrointestinal absorption of drugs: methods and studies. Fundam Clin Pharmacol 1999; 13: 154-168. (Pubitemid 32324243)
16. Porter CJ, Trevaskis NL, Charman WN,. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007; 6: 231-248. (Pubitemid 46344627)
17. Narushima K, Takada T, Yamanashi Y, Suzuki H,. Niemann-pick C1-like 1 mediates alpha-tocopherol transport. Mol Pharmacol 2008; 74: 42-49. (Pubitemid 351872157)
18. Abuasal B, Sylvester PW, Kaddoumi A,. Intestinal absorption of gamma-tocotrienol is mediated by Niemann-Pick C1-like 1: in situ rat intestinal perfusion studies. Drug Metab Dispos 2010; 38: 939-945.
19. Amidon GL, Lennernas H, Shah VP, Crison JR,. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12: 413-420.
20. Hollander D, Rim E, Muralidhara KS,. Mechanism and site of small intestinal absorption of alpha-tocopherol in the rat. Gastroenterology 1975; 68: 1492-1499.
21. Bjorneboe A, Bjorneboe GE, Bodd E, Hagen BF, Kveseth N, Drevon CA,. Transport and distribution of alpha-tocopherol in lymph, serum and liver cells in rats. Biochim Biophys Acta 1986; 889: 310-315. (Pubitemid 17229824)
22. Fatouros DG, Mullertz A,. In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Expert Opin Drug Metab Toxicol 2008; 4: 65-76. (Pubitemid 351234101)
23. Larsen AT, Sassene P, Mullertz A,. In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems. Int J Pharm 2011; 417: 245-255.
24. Dahan A, Hoffman A,. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur J Pharm Biopharm 2007; 67: 96-105. (Pubitemid 46991342)
25. Ali H, Nazzal M, Zaghloul AA, Nazzal S,. Comparison between lipolysis and compendial dissolution as alternative techniques for the in vitro characterization of alpha-tocopherol self-emulsified drug delivery systems (SEDDS). Int J Pharm 2008; 352: 104-114.
26. Sassene PJ, Knopp MM, Hesselkilde JZ, et al,. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. J Pharm Sci 2010; 99: 4982-4991.
27. Garcia-Calvo M, Lisnock J, Bull HG, et al,. The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). Proc Natl Acad Sci USA 2005; 102: 8132-8137. (Pubitemid 40800055)
28. Davis HR, Veltri EP,. Zetia: inhibition of Niemann-Pick C1 like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. J Atheroscler Thromb 2007; 14: 99-108.
29. Svensson US, Sandstrom R, Carlborg O, Lennernas H, Ashton M,. High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement. Drug Metab Dispos 1999; 27: 227-232. (Pubitemid 29072076)
30. Yu L,. The structure and function of Niemann-Pick C1-like 1 protein. Curr Opin Lipidol 2008; 19: 263-269. (Pubitemid 351653564)
31. Yu L, Bharadwaj S, Brown JM, et al,. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem 2006; 281: 6616-6624. (Pubitemid 43847596)
32. Abuasal B, Thomas S, Sylvester PW, Kaddoumi A,. Development and validation of a reversed-phase HPLC method for the determination of gamma-tocotrienol in rat and human plasma. Biomed Chromatogr 2011; 25: 621-627.
33. Cao X, Gibbs ST, Fang L, et al,. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res 2006; 23: 1675-1686. (Pubitemid 44200529)
34. Min CK,. Structure and Function of α-Tocopherol Transfer Protein: Implications for Vitamin E Metabolism and AVED. In Vitamin E: Vitamins and Hormones Advances in Research and Applications, Litwack G, (ed). Elsevier Inc: San Diego, 2007; 23-43.
35. Prabhu S, Ortega M, Ma C,. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Int J Pharm 2005; 301: 209-216. (Pubitemid 41206605)
36. Sugano K, Kansy M, Artursson P, et al,. Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov 2010; 9: 597-614.
37. Abuasal BS, Bolger MB, Walker DK, Kaddoumi A,. In silico modeling for the nonlinear absorption kinetics of UK-343,664: A P-gp and CYP3A4 substrate. Mol Pharm 2012; 9: 492-504.
38. Johnson DA, Amidon GL,. Determination of intrinsic membrane transport parameters from perfused intestine experiments: a boundary layer approach to estimating the aqueous and unbiased membrane permeabilities. J Theor Biol 1988; 131: 93-106.
39. Abuasal BS, Lucas C, Peyton B, Alayoubi A, Nazzal S, Sylvester PW, Kaddoumi A,. Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases gamma-tocotrienol oral bioavailability. Lipids 2012; 47: 461-469.
40. Sontag TJ, Parker RS,. Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega- hydroxylase. J Lipid Res 2007; 48: 1090-1098. (Pubitemid 46708676)